Virtual Presentation with CME Points

Thank you for your interest. Registration is now closed.
Topic

Introduction to Novel Super High Flux Sharp Cut-off Membrane Dialyzer

Time

Oct 11, 2022 02:00 PM – 3.00PM (GMT +8) in Singapore

Agenda

2.00PM – Introduction

2.05PM – Efficiency of Novel Super High Flux Sharp Cut-Off Membrane Dialyzer

2.40PM – Discussion and Q&A

3.00PM – Closing

Summary

A SUPER HIGH FLUX SHARP CUT-OFF

Elisio-HX Polyetersulfone (PES) Membrane:

• Excellent solute removal
• High removal in low molecular weight protein
• Low protein leakage

Speakers

Dr. Behram A. Khan (Moderator)
Medical Director, NKF
Adj Asst. Professor, NUS
Senior Consultant Nephrologist, NUH
Chairperson, Singapore

Dr. Haruki Wakai, M.D. (Speaker)
President of Reiseikai Medical Corporation
Director & owner of Shinagawa Garden Clinic Assistant director & owner of Gotanda Garden Clinic Secretary of Japanese Society for Home Hemodialysis Japan

A day-long conference titled, “International CME on Kidney Disease and Hemodialysis” was held in Dhaka on Monday, 29 August, 2022. The conference was organized by Bangladesh Renal Association and powered by NIPRO-JMI Medical Limited, a Japan-Bangladesh joint venture company.

Representative speaker & Executive Director of NIPRO JMI Medical Ltd, Kunio (Kenny) Takamido started the session to introduce Nipro Corporation and its product range. Distinguished speakers at the conference discussed how to avoid kidney disease and ensure affordable renal care. The sessions at the international conference were on “Water quality in hemodialysis – Correlation between high-quality water and affordable care”; “Dialyzer – Effective selection to better patients’ outcome for affordable care; and the world knowledge” and the recent trend of dialysis, with real international case studies from Singapore, Europe, and Japan.

Joining the panel was Ahmed Showki Arnob, MRCSEd from Kettering General Hospital Northamptonshire, United Kingdom; Dr. M. Muhibur Rahman, Professor of Nephrology, Popular Medical College and Hospital; Dr. Srinivas Subramanian, Director and Physician of Dr. Sri’s Kidney and Medical Clinic, Parkway East Hospital, Singapore; Dr. Behram Ali Khan, Medical Director of The National Kidney Foundation, Singapore; presented their papers and experience as the speakers at the conference.

Attending the event was President of Bangladesh Renal Association and Professor of Nephrology Department of Bangabandhu Sheikh Mujib Medical University (BSMMU) Dr. Muhammad Rafiqul Alam attended the conference as the chief guest, while Secretary General of Bangladesh Renal Association and Professor of Nephrology Department of BSMMU Dr. K B M Hadiuzzaman as special guests.

Professor and Chairman of Department of Nephrology of BSMMU Dr. Muhammad Nazrul Islam on the chair, the event was also attended by the Founding Managing Director of JMI Group Md. Abdur Razzaq.

It was disclosed at the conference that only 40 percent of the infected patients with kidney disease have been receiving dialysis services across the country. As a result, a large number of patients are dying without treatment. For this, the speakers emphasized ensuring affordable care for renal patients. They also suggested creating awareness about kidney disease and starting treatment at the early stage of the disease.

Speakers also urged the physicians as well as businesses to work in a combined approach to fulfill the government’s vision to ensure no kidney patient will die without treatment. The conclusion of the session had invited 150 nephrologists with high interest.

Nipro Virtual Presentation on Zoom

In collaboration with Singapore’s Integrated Healthcare Holdings (IHH). Learn more about NSI, phlebitis, or any IV related complications during our online zoom webinar

Topic

Webinar: NSI, phlebitis, or any IV related complications

Time

17 August 2022 01:00 PM – 1.30PM (GMT +8) in SG

Speakers

Siti Samira
Nurse Manager
Pandemic Coordinator
Mount Elizabeth Hospital
Singapore 

Nr. Ren Dacui 
Nurse Clinician
Infection Control Officer
Mount Elizabeth Hospital
Singapore
Thank you for your interest. Registration is now closed.

Invitation to CLFine™ Launch Session

 
DATE: 29ᵗʰ JULY 2022
TIME: 7.00 – 9.00 PM (SG Time)
VENUE: MANDARIN ORIENTAL HOTEL,
ATRIUM SUITE 1 & 2
5 Raffles Avenue Marina Square,
Singapore 039797

 

AGENDA:

1. Microbiological analysis concerning antimicrobial effect of atomized
Ionless™ hypochlorous acid water in a hospital environment

Presented by Miho Miura , R, N.
Deputy Director & Certified Nurse
Division of Infection Control & Prevention
Kurume University Hospital, Japan

2. Ionless™ Hypochlorous Acid Water(CL Fine™)as Infection Control Measure.
Presented by Naohisa Kawamura, Ph. D.
Director, Pharmaceutical Division
Saitama Research Center
Nipro Corporation, Japan

3. Basic of Hypochlorous acid water & usage in Japan
Presented by Takuya Miyatake,
Deputy Manager
Global Business Division
Nipro Corporation, Japan

4. Q&A session

5. Closing

 

Thank you for your interest. Registration is now closed.

Bangladesh is expected as a large consumption market with its 8th largest population in the world, as well as playing an important role as a cost-effective production base. Although Bangladesh has been experiencing drastic economic growth, there are still decent number of people who cannot access to healthcare service out of poverty.

On May 31st  2022, an event to celebrate the 12th anniversary of NIPRO’s joint venture in Bangladesh was held, with the presence of the ministers of Bangladesh, the ambassador of Japan, the chairman of medical practitioners and NIPRO management. 

NIPRO as a global leading company, has put the largest effort in order to supply high quality medical devices and pharmaceuticals, to contribute to the improvement on the access to healthcare in the country. Since 2010, NIPRO has been localizing itself by making a partnership with the local company “JMI Group” and demonstrates its commitment as a local manufacturer of medical devices and pharmaceuticals and a dialysis service provider with; NIPRO JMI Company Ltd., NIPRO JMI Pharma Ltd., JMI Syringes & Medical Devices Ltd, NIPRO JMI Medical Ltd. and NIPRO JMI Dialysis Center Ltd.

The NIPRO’s strong commitment and contribution to the healthcare society in Bangladesh demonstrated in the event was well recognized and 10 newspaper and 4 TV media released the news. Taking advantage of the brand recognition, NIPRO will take further steps to bond with local customers and seek for the further business growth.

NewsWeek interviews Nipro

Nipro is very successful at identifying a problem and providing the solutions both in Japan and internationally. How has this success been achieved, and how does Nipro encourage employees?

Nipro President, Yoshihiko Sano shares:

Our motto is “Willingness”, we encourage our employees to be actively involved in the planning phase and to be convinced with what they are trying to do. It is also necessary for them to have an in-depth understanding of the plan they are making. If we see an opportunity with any plan designed by our employees, we never decline our customers’ requests. This is the kind of culture that we have at NIPRO. We have more than thirty thousand employees and we understand that it would take time for everyone to fully understand this culture, however, this is deeply rooted in their hearts.

It is necessary for employees to have an in-depth understanding of the plan they are making.
YOSHIHIKO SANO, PRESIDENT

 

Speaking of our sales representatives, if they receive complaints from our clients, these are easily communicated but not when they receive compliments. Therefore, we encourage them to communicate these compliments as well.

NewsWeek interviews Nipro

When our Nipro President, Mr. Sano, retires and hands over the company to the next generation of executives, what kind of legacy would he like to leave, and which corporate value stands out for him?

Nipro President, Mr. Sano, replies:

My hope is to have Nipro’s culture which is Willingness to take root firmly. I would like to see my employees have their own plans and to just do them, to approach every activity with “Willingness” in accordance with our corporate creed. Willingness to adopt the patient’s point of view in order to provide beneficial products, Willingness to continuously develop our businesses and strive for self-actualization, and Willingness to create new value worldwide through the cooperation and the self-actualization of all Nipro employees.

Approach every activity with “Willingness”!
YOSHIHIKO SANO, PRESIDENT

Nipro Corporation unveiled the company’s innovative disposable syringes, a timely solution that can stretch the Covid-19 vaccine dosage amid an increase in Covid-19 infections. DOSESAVER™ can help reduce vaccine wastage, allowing more people to be vaccinated. The Nipro Sales team in Thailand were recently featured on Thai media, Biz Journey. Watch DOSESAVER™ in action on the Bangkok Post & Post Today video. Learn about Nipro’s history with Thailand and more.

Featured on:

Nipro Virtual Presentation on Zoom

Agenda

• Introduction
• Evolution of Membrane & Benefits
• Discussion and Q&A
• Closing

Topic

Evolution of Membrane and Benefits

Time

Jul 27, 2022 02:00 PM – 2.45PM (GMT +8) in SG

Speakers

Prof. Dusit Lumlertgul
Renal Division, Department of Medicine, Faculty of Medicine, Chiang Mai University, Thailand

Antony Inbaraj
Clinical Manager
Nipro Asia
Singapore 
Thank you for your interest. Registration is now closed.